RJA
AMTX icon

Raymond James & Associates’s Aemetis AMTX Stock Holding History

Raymond James & Associates’s Portfolio AMTX Stock Details AMTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-18,120
Closed -$230K – 4024
2022
Q1 		$230K Buy
18,120
+7,097
+64% +$78.2K ﹤0.01% 3586
2021
Q4 		$136K Buy
+11,023
New +$195K ﹤0.01% 3799

Other funds holding AMTX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Grantham, Mayo, Van Otterloo & Co (GMO)
Grantham, Mayo, Van Otterloo & Co (GMO) Boston, Massachusetts $39.1B AUM 28.69% 1-Year Est. Return
ECA
Encompass Capital Advisors New York $3.34B AUM 167.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
CIBC Private Wealth Group
CIBC Private Wealth Group Atlanta, Georgia $59.2B AUM 20.62% 1-Year Est. Return

Raymond James & Associates's AMTX Position: Q2 2022 in Review

Raymond James & Associates sold out of Aemetis (AMTX) in Q2 2022, closing a stake of 18,120 shares — an estimated $230K sold.

Raymond James & Associates first reported a position in AMTX in Q4 2021 and held it in 2 quarters. The position peaked at $230K in Q1 2022. 83 funds tracked by Wall St. Rank hold AMTX as of Q2 2022.

  • Raymond James & Associates reported no remaining Aemetis position as of Q2 2022 after selling out during the quarter.
  • Raymond James & Associates sold 18,120 Aemetis shares in Q2 2022, an estimated $230K.
  • Raymond James & Associates first reported a position in Aemetis in Q4 2021 and held it in 2 quarters.
  • Raymond James & Associates's Aemetis position peaked at $230K in Q1 2022.
  • 83 funds tracked by Wall St. Rank held Aemetis as of Q2 2022.

Based on Raymond James & Associates's 13F filing for Q2 2022, filed 12 Aug 2022.